Subsequents Events - Additional Information (Details) - USD ($) | | | 3 Months Ended | | | | | |
Oct. 12, 2023 | Feb. 07, 2023 | Sep. 30, 2023 | Dec. 31, 2022 | Sep. 30, 2024 | Jun. 30, 2024 | Mar. 31, 2024 | Dec. 31, 2023 | Oct. 31, 2023 |
Subsequent Event [Line Items] | | | | | | | | | |
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | | | $ 1.26 | | | | | | |
Stock Options, Granted | | | 359,214 | | | | | | |
Board of Directors Chairman | | | | | | | | | |
Subsequent Event [Line Items] | | | | | | | | | |
Base salary | | $ 212,500 | | | | | | | |
Interim Chief Executive Officer | | | | | | | | | |
Subsequent Event [Line Items] | | | | | | | | | |
Base salary | | $ 17,500 | | | | | | | |
Restricted Stock Units (RSUs) [Member] | | | | | | | | | |
Subsequent Event [Line Items] | | | | | | | | | |
Weighted average period | | | 2 years 4 months 24 days | | | | | | |
Fourth Amendment | | | | | | | | | |
Subsequent Event [Line Items] | | | | | | | | | |
Debt instrument covenant description | (i) waives certain existing events of default relating to the Company’s failure to comply with the financial covenants and financial reporting requirements set forth in the credit agreement for prior fiscal periods; (ii) reduces the aggregate revolving commitment and the aggregate delayed draw term loan commitment to $200,000,000 and $38,100,000, respectively; (iii) replaces the maximum debt to capitalization financial covenant with a minimum adjusted EBITDA financial covenant of not less than (1) $4,000,000 for the fiscal quarter ending September 30, 2023, (2) $17,000,000 for the two fiscal quarter period ending December 31, 2023, (3) $27,000,000 for the three fiscal quarter period ending March 31, 2024, (4) $34,000,000 for the four fiscal quarter period ending June 30, 2024, and (5) $35,000,000 for each four fiscal quarter period ending thereafter; (iv) adds a minimum liquidity covenant of $25,000,000 (or, for fiscal quarters ending in December, $15,000,000), which applies only for the fiscal quarters ending September 30, 2023 through and including December 31, 2024 (the “Covenant Modification Period”); (v) suspends the minimum fixed charge coverage ratio covenant for the fiscal quarters ending September 30, 2023 through and including June 30, 2024 and provides for a step-down of the minimum fixed charge coverage ratio to 1.00:1.00 for the remainder of the Covenant Modification Period; (vi) adds an equity cure right for the Company in the event of future breaches of the financial covenants; (vii) reduces revolver availability by (1) $15,000,000 during the months of February through September of each year and (2) $10,000,000 during the months of October through January of each year; (viii) suspends the exercise of incremental facilities during the Covenant Modification Period; (ix) restricts all permitted acquisitions during the term of the credit facilities, unless previously approved by the required Lenders; (x) increases in the applicable margin for all credit facilities to 3.00% for the loans subject to SOFR interest rates (the "SOFR Loans") and 2.00% for the loans subject to the Adjusted Base Rate (the "ABR Loans"), which margins will step-up further if certain prepayments of the term loans are not made by certain dates prescribed in the Fourth Amendment; (xi) adds additional mandatory prepayments of (1) $10,000,000 by no later than March 31, 2024, (2) an additional $10,000,000 by no later than June 30, 2024 and (3) an additional $25,000,000 by no later than December 31, 2024; (xii) adds additional mandatory prepayments in the event that the Borrowers maintain a cash balance in excess of $20,000,000; (xiii) permits additional sales of certain real property with an aggregate appraised value of approximately $60,000,000, in addition to related personal property assets; and (xiv) adds certain additional reporting requirements to Agent and the Lenders. | | | | | | | | |
Minimum liquidity covenant | | | | $ 15,000,000 | | | | | |
Fiscal quarter ending September 30, 2023 | | | $ 4,000,000 | | | | | | |
Fourth Amendment | Forecast | | | | | | | | | |
Subsequent Event [Line Items] | | | | | | | | | |
Fiscal quarter period ending December 31, 2023 | | | | | | | | $ 17,000,000 | |
Fiscal quarter period ending March 31, 2024 | | | | | | | $ 27,000,000 | | |
Fiscal quarter period ending June 30, 2024 | | | | | | $ 34,000,000 | | | |
Thereafter | | | | | $ 35,000,000 | | | | |
Subsequent Event | | | | | | | | | |
Subsequent Event [Line Items] | | | | | | | | | |
Debt instrument covenant description | (i) waives certain existing events of default relating to the Company’s failure to comply with the financial covenants and financial reporting requirements set forth in the credit agreement for prior fiscal periods; (ii) reduces the aggregate revolving commitment and the aggregate delayed draw term loan commitment to $200,000,000 and $38,100,000, respectively; (iii) replaces the maximum debt to capitalization financial covenant with a minimum adjusted EBITDA financial covenant of not less than (1) $4,000,000 for the fiscal quarter ending September 30, 2023, (2) $17,000,000 for the two fiscal quarter period ending December 31, 2023, (3) $27,000,000 for the three fiscal quarter period ending March 31, 2024, (4) $34,000,000 for the four fiscal quarter period ending June 30, 2024, and (5) $35,000,000 for each four fiscal quarter period ending thereafter; (iv) adds a minimum liquidity covenant of $25,000,000 (or, for fiscal quarters ending in December, $15,000,000), which applies only for the fiscal quarters ending September 30, 2023 through and including December 31, 2024 (the “Covenant Modification Period”); (v) suspends the minimum fixed charge coverage ratio covenant for the fiscal quarters ending September 30, 2023 through and including June 30, 2024 and provides for a step-down of the minimum fixed charge coverage ratio to 1.00:1.00 for the remainder of the Covenant Modification Period; (vi) adds an equity cure right for the Company in the event of future breaches of the financial covenants; (vii) reduces revolver availability by (1) $15,000,000 during the months of February through September of each year and (2) $10,000,000 during the months of October through January of each year; (viii) suspends the exercise of incremental facilities during the Covenant Modification Period; (ix) restricts all permitted acquisitions during the term of the credit facilities, unless previously approved by the required Lenders; (x) increases in the applicable margin for all credit facilities to 3.00% for SOFR Loans and 2.00% for ABR Loans, which margins will step-up further if certain prepayments of the term loans are not made by certain dates prescribed in the Fourth Amendment; (xi) adds additional mandatory prepayments of (1) $10,000,000 by no later than March 31, 2024, (2) an additional $10,000,000 by no later than June 30, 2024 and (3) an additional $25,000,000 by no later than December 31, 2024; (xii) adds additional mandatory prepayments in the event that the Borrowers maintain a cash balance in excess of $20,000,000; (xiii) permits additional sales of certain real property with an aggregate appraised value of approximately $60,000,000, in addition to related personal property assets; and (xiv) adds certain additional reporting requirements to Agent and the Lenders. | | | | | | | | |
Subsequent Event | February through September | | | | | | | | | |
Subsequent Event [Line Items] | | | | | | | | | |
Available amount under line of credit | $ 15,000,000 | | | | | | | | |
Subsequent Event | Fourth Amendment | | | | | | | | | |
Subsequent Event [Line Items] | | | | | | | | | |
Minimum liquidity covenant | 25,000,000 | | | | | | | | |
Fiscal quarter ending September 30, 2023 | 4,000,000 | | | | | | | | |
Fiscal quarter period ending December 31, 2023 | 17,000,000 | | | | | | | | |
Fiscal quarter period ending March 31, 2024 | 27,000,000 | | | | | | | | |
Fiscal quarter period ending June 30, 2024 | 34,000,000 | | | | | | | | |
Thereafter | 35,000,000 | | | | | | | | |
Debt instrument, periodic payment | 20,000,000 | | | | | | | | |
Line of credit facility covenant aggregate appraised value | 60,000,000 | | | | | | | | |
Subsequent Event | Fourth Amendment | March 31, 2024 | | | | | | | | | |
Subsequent Event [Line Items] | | | | | | | | | |
Debt instrument, periodic payment | 10,000,000 | | | | | | | | |
Subsequent Event | Fourth Amendment | June 30, 2024 | | | | | | | | | |
Subsequent Event [Line Items] | | | | | | | | | |
Debt instrument, periodic payment | 10,000,000 | | | | | | | | |
Subsequent Event | Fourth Amendment | December 31, 2024 | | | | | | | | | |
Subsequent Event [Line Items] | | | | | | | | | |
Debt instrument, periodic payment | 25,000,000 | | | | | | | | |
Subsequent Event | Fourth Amendment | February through September | | | | | | | | | |
Subsequent Event [Line Items] | | | | | | | | | |
Available amount under line of credit | 15,000,000 | | | | | | | | |
Subsequent Event | Fourth Amendment | October through January | | | | | | | | | |
Subsequent Event [Line Items] | | | | | | | | | |
Available amount under line of credit | 10,000,000 | | | | | | | | $ 10,000,000 |
Subsequent Event | Fourth Amendment | Revolving Credit Facility | | | | | | | | | |
Subsequent Event [Line Items] | | | | | | | | | |
Maximum borrowing capacity | 200,000,000 | | | | | | | | |
Subsequent Event | Fourth Amendment | Delay Draw Term Loan Facility | | | | | | | | | |
Subsequent Event [Line Items] | | | | | | | | | |
Maximum borrowing capacity | $ 38,100,000 | | | | | | | | |
Subsequent Event | Fourth Amendment | Secured Overnight Financing Rate (SOFR) | | | | | | | | | |
Subsequent Event [Line Items] | | | | | | | | | |
Debt instrument, interest rate | 3% | | | | | | | | |
Debt instrument, basis spread on variable rate | 3% | | | | | | | | |
Subsequent Event | Fourth Amendment | Alternate Base Rate | | | | | | | | | |
Subsequent Event [Line Items] | | | | | | | | | |
Debt instrument, interest rate | 2% | | | | | | | | |
Debt instrument, basis spread on variable rate | 2% | | | | | | | | |